Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Tian, Jun-qiang"" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł :
Proof-of-Concept and Feasibility Study to Evaluate the Effect of β-Glucan on Protective Qi Deficiency in Adults.
Autorzy :
Levy M; Research and Development Department, USANA Health Science, Inc., Salt Lake City, UT, 84121, USA.
Wu JR; Elegant and Olive Health Clinic, Markham, ON, L3R 5V6, Canada.
Shi JP; Elegant and Olive Health Clinic, Markham, ON, L3R 5V6, Canada.
Cheng HJ; Research and Development Department, USANA Health Science, Inc., Salt Lake City, UT, 84121, USA.
Qu XQ; Elegant and Olive Health Clinic, Markham, ON, L3R 5V6, Canada.
Bernstein I; Department of Family and Community Medicine, Humber River Hospital, Toronto, ON, M1V 2W7, Canada.
Sinnott R; Research and Development Department, USANA Health Science, Inc., Salt Lake City, UT, 84121, USA.
Tian JQ; Research and Development Department, USANA Health Science, Inc., Salt Lake City, UT, 84121, USA. Jeremy.tian@us.usana.com.
Pokaż więcej
Źródło :
Chinese journal of integrative medicine [Chin J Integr Med] 2021 Sep; Vol. 27 (9), pp. 666-673. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
β -Glucan Improves Protective Qi Status in Adults with Protective Qi Deficiency-A Randomized, Placebo-Controlled, and Double-Blinded Trial.
Autorzy :
Wu JR; Elegant and Olive Health Clinic, Markham, ON, L3R 5V6, Canada.
Cheng HJ; Research and Development Department, USANA Health Science, Inc., Salt Lake City, UT, 84121, USA.
Shi JP; Elegant and Olive Health Clinic, Markham, ON, L3R 5V6, Canada.
Yin WD; Elegant and Olive Health Clinic, Markham, ON, L3R 5V6, Canada.
Wang J; Elegant and Olive Health Clinic, Markham, ON, L3R 5V6, Canada.
Ou XQ; Elegant and Olive Health Clinic, Markham, ON, L3R 5V6, Canada.
Chen JL; Elegant and Olive Health Clinic, Markham, ON, L3R 5V6, Canada.
Bernstein I; Department of Family and Community Medicine, University of Toronto, Toronto, ON, M5T 2S8, Canada.
Levy M; Research and Development Department, USANA Health Science, Inc., Salt Lake City, UT, 84121, USA.
Maddela R; Research and Development Department, USANA Health Science, Inc., Salt Lake City, UT, 84121, USA.
Sinnott R; Research and Development Department, USANA Health Science, Inc., Salt Lake City, UT, 84121, USA.
Tian JQ; Research and Development Department, USANA Health Science, Inc., Salt Lake City, UT, 84121, USA. jeremy.tian@usanainc.com.
Pokaż więcej
Źródło :
Chinese journal of integrative medicine [Chin J Integr Med] 2021 May 08. Date of Electronic Publication: 2021 May 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Testicular Metastasis from Urothelial Carcinoma of the Renal Pelvis: A Rare Case and Review of the Literature.
Autorzy :
Wu XW; Department of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou 730000, People's Republic of China.
Zhang Y; Department of Ultrasound in Medicine, Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai Institute of Ultrasound in Medicine, Shanghai 200233, People's Republic of China.
Li YF; Department of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou 730000, People's Republic of China.
Li Y; Department of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou 730000, People's Republic of China.
Zhang XX; Department of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou 730000, People's Republic of China.
Wang W; Department of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou 730000, People's Republic of China.
Ma JH; Department of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou 730000, People's Republic of China.
Wang PL; Department of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou 730000, People's Republic of China.
Dong ZC; Department of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou 730000, People's Republic of China.
Shi W; Department of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou 730000, People's Republic of China.
Tian JQ; Department of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou 730000, People's Republic of China.
Pokaż więcej
Źródło :
OncoTargets and therapy [Onco Targets Ther] 2020 Jan 30; Vol. 13, pp. 915-920. Date of Electronic Publication: 2020 Jan 30 (Print Publication: 2020).
Typ publikacji :
Case Reports
Raport
Tytuł :
Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer.
Autorzy :
Shang PF; Department of Urology, Second Hospital of Lanzhou University, No. 82, Cui Ying Men Street, Lanzhou City, Gansu, China, 730030.
Kwong J
Wang ZP
Tian J
Jiang L
Yang K
Yue ZJ
Tian JQ
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2011 May 11 (5). Cochrane AN: CD006885. Date of Electronic Publication: 2011 May 11.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Adjuvants, Immunologic/*administration & dosage
Antibiotics, Antineoplastic/*administration & dosage
BCG Vaccine/*administration & dosage
Epirubicin/*administration & dosage
Urinary Bladder Neoplasms/*drug therapy
Adjuvants, Immunologic/adverse effects ; Administration, Intravesical ; BCG Vaccine/adverse effects ; Humans ; Neoplasm Recurrence, Local/prevention & control ; Randomized Controlled Trials as Topic ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/prevention & control
Czasopismo naukowe
Tytuł :
Dendritic cell transfected with secondary lymphoid-tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cell S in vitro.
Autorzy :
Li YG; Institute of Urology, Lanzhou University Second Hospital, Lanzhou University Clinical Medical College, Lanzhou, China.
Wang ZP
Tian JQ
Tian BQ
Rodrigues R
Shang PF
Zhang T
Pokaż więcej
Źródło :
Cancer investigation [Cancer Invest] 2009 Nov; Vol. 27 (9), pp. 909-17.
Typ publikacji :
Journal Article
MeSH Terms :
Autocrine Communication*
Cytotoxicity, Immunologic*
Immunotherapy, Adoptive*
Chemokine CCL21/*biosynthesis
Dendritic Cells/*transplantation
Interleukin-2/*biosynthesis
T-Lymphocytes/*immunology
Urinary Bladder Neoplasms/*therapy
Apoptosis ; Blotting, Western ; Cell Line, Tumor ; Cell Proliferation ; Chemokine CCL21/genetics ; Coculture Techniques ; Dendritic Cells/immunology ; Enzyme-Linked Immunosorbent Assay ; Flow Cytometry ; Humans ; Interleukin-2/genetics ; Polymerase Chain Reaction ; T-Lymphocytes, Regulatory/immunology ; Time Factors ; Transfection ; Urinary Bladder Neoplasms/immunology ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell.
Autorzy :
He XD; Institute of Urology, Second Hospital of Lanzhou University, Lanzhou, PR China.
Wang ZP
Wei HY
Zhou Q
Wang DG
Tian JQ
Fu SJ
Rodriguez R
Pokaż więcej
Źródło :
Urologia internationalis [Urol Int] 2009; Vol. 82 (2), pp. 209-13. Date of Electronic Publication: 2009 Mar 19.
Typ publikacji :
Journal Article
MeSH Terms :
Genetic Vectors*
Promoter Regions, Genetic*
Transfection*
Adenoviridae/*genetics
Adenovirus E1A Proteins/*metabolism
Genetic Therapy/*methods
Membrane Proteins/*metabolism
Receptors, Virus/*metabolism
Urinary Bladder Neoplasms/*metabolism
Urothelium/*metabolism
Adenovirus E1A Proteins/genetics ; Cell Line, Tumor ; Cell Survival ; Coxsackie and Adenovirus Receptor-Like Membrane Protein ; Humans ; Membrane Proteins/genetics ; Receptors, Virus/genetics ; Time Factors ; Urinary Bladder Neoplasms/genetics ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/therapy ; Uroplakin II ; Urothelium/pathology
Czasopismo naukowe
Tytuł :
In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
Autorzy :
Tian JQ; Lanzhou University School of Life Science, Lanzhou, GanSu, China.
Wang ZP
Rodriguez R
Fu JS
Lu JZ
Ma BL
Pokaż więcej
Źródło :
Urology [Urology] 2006 May; Vol. 67 (5), pp. 1093-8. Date of Electronic Publication: 2006 Apr 25.
Typ publikacji :
Journal Article
MeSH Terms :
Apoptosis/*immunology
Apoptosis Regulatory Proteins/*immunology
Cytotoxicity, Immunologic/*immunology
Interleukin-2/*immunology
Lymphocytes, Tumor-Infiltrating/*immunology
Membrane Glycoproteins/*immunology
Tumor Necrosis Factor-alpha/*immunology
Apoptosis/genetics ; Apoptosis Regulatory Proteins/genetics ; Carcinoma, Renal Cell/genetics ; Cell Line ; Cell Line, Tumor ; Cytotoxicity Tests, Immunologic ; Cytotoxicity, Immunologic/genetics ; Genetic Vectors ; Humans ; Intercellular Adhesion Molecule-1/biosynthesis ; Interleukin-2/genetics ; Membrane Glycoproteins/genetics ; Protein Biosynthesis/genetics ; TNF-Related Apoptosis-Inducing Ligand ; Transfection ; Tumor Necrosis Factor-alpha/genetics
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies